Oura Is Thinking Beyond the Ring: Inside the Company’s Move Into AR Smart Glasses
The Finnish wearable giant is quietly building a future where your health data floats before your eyes, while your ring controls what you see.
In the decade since Oura launched its first titanium sleep tracker, the company has built an $11 billion empire on a single, elegantly simple premise: the finger is the best place to measure the human body. Now, a recently uncovered patent suggests Oura is preparing for its most ambitious expansion yet: one that could transform the humble smart ring from a passive sensor into the command centre for an augmented reality ecosystem.
Patent application 20260023426, filed in July 2025 and published this January, reveals Oura’s vision for AR smart glasses that display real-time biometric data directly in the user’s field of view, all controlled through subtle gestures detected by the ring itself . The filing represents more than a product concept; it signals a strategic inflection point for a company that has sold over 5.5 million rings but faces mounting pressure from tech giants encroaching on its territory.
The Patent: A Window Into Oura’s Ambitions
The technical specifications outlined in the patent describe a multi-device system where the Oura Ring serves as both biometric sensor and input controller for a pair of smart glasses equipped with heads-up display (HUD) technology . Heart rate, body temperature, movement data, and other physiological metrics would beam directly into the wearer’s line of sight, eliminating the need to check a smartphone or watch during workouts, meetings, or daily activities.
What distinguishes this approach from existing AR health applications is the integration of contextual intelligence. The patent describes an onboard camera capable of automatically recording environmental footage during “abnormally” high heart rate readings, creating a visual diary of physiological events . Imagine your glasses capturing the scene during a stressful presentation or an intense workout, then correlating that visual context with your biometric spike, transforming raw data into actionable narrative.
The gesture control system leverages the ring’s position on the finger to detect subtle hand movements. Rotating the ring, making a fist, or specific finger motions could trigger actions like capturing photos, dismissing data overlays, or switching between health metrics . In one scenario described in the filing, a runner could adjust workout intensity on the fly by glancing at their heart rate without breaking stride or touching their face.
Security is woven into the hardware relationship: the ring serves as an identity key, and without it nearby, the glasses remain locked, protecting sensitive health data from unauthorised access .
The Talent Behind the Technology
Perhaps more telling than the technical details are the names attached to the patent. Several inventors listed on the filing hail from AR teams at major tech firms, including Meta . This isn’t a team assembled for defensive intellectual property purposes; these are specialists in optical hardware, computer vision, and spatial computing. Their presence suggests Oura is building genuine capability in advanced display technology, not merely sketching speculative concepts.
The glasses described in the patent go far beyond simple notification mirrors. They include integrated lenses, microphones, speakers, and a display system capable of sophisticated visual overlays . This is the architecture of a full-featured AR device, not a peripheral accessory.
Strategic Context: Why Now?
Oura’s exploration of augmented reality comes at a pivotal moment for the company. In October 2025, Oura closed a $900 million Series E funding round led by Fidelity Management & Research Company, doubling its valuation to $11 billion. The company was on track to generate $1 billion in revenue for 2025, having sold nearly 3 million rings in the previous twelve months.
Yet CEO Tom Hale faces a classic innovator’s dilemma. Oura’s success has attracted formidable competition: Samsung launched its Galaxy Ring in July 2024, whilst Apple continues to expand the health capabilities of the Apple Watch, most recently adding hypertension notifications and sleep score to the Series 11 and Ultra 3 in September 2025, and Google unveiled an AI-powered personal health coach for its Fitbit platform in August 2025. The ring form factor, once Oura’s unique differentiator, is becoming crowded.
In interviews, Hale has hinted at a “cloud of wearables” future, where Oura’s technology extends beyond the finger into multiple devices and sensors. Speaking at Fortune Brainstorm Tech in September 2025, he suggested that whether “it’s metabolic [monitoring], maybe it’s blood pressure, maybe it’s activity, maybe it’s other things,” the future lies in a network of specialised devices rather than a single product. He has emphasised that Oura would likely partner rather than build all these devices itself. The AR glasses patent suggests a more expansive vision, one where Oura doesn’t merely supply sensors but orchestrates entire ecosystems of health-aware devices.
The Competitive Landscape
Oura is not alone in exploring ring-controlled AR. Samsung has begun integrating its Galaxy Ring with its XR headset initiatives, with code discovered in November 2025 revealing gesture controls for upcoming Galaxy Glasses, whilst startups like Even Realities and Inmo have already launched smart rings specifically to control their AR glasses. Meta’s Ray-Ban smart glasses, though not health-focused, have proven consumer appetite for wearable cameras and displays; the company launched two sports-oriented Oakley-branded models in 2025, the HSTN in June and the Vanguard in September. What Oura brings to this emerging category is a decade of expertise in physiological sensing and, crucially, user trust.
The company has positioned itself as a health guardian rather than a tech gadget maker, emphasising clinical-grade accuracy and data privacy. In an era of increasing scepticism toward big tech’s handling of personal information, Oura’s independence, Hale has suggested, may prove a competitive advantage; when asked about acquisition by larger competitors, he cited the potential loss of user trust as a reason to maintain the company’s autonomy.
From Data to Narrative
The most revolutionary aspect of Oura’s AR vision isn’t the display technology—it’s the potential to close the loop between biometric measurement and contextual understanding. Current wearables tell users that something happened: your heart rate spiked, your temperature rose, your sleep was disrupted. But they rarely explain why.
By pairing continuous biometric monitoring with environmental sensing through camera-equipped glasses, Oura could create what the patent describes as “storytelling”—bridging the gap between physiological events and their triggers . If your heart rate jumps during lunch, the system might recognise you’re eating and log the visual of your meal alongside the biometric data. If stress peaks during a particular meeting, the glasses could capture the context, helping users identify patterns invisible to current devices.
This aligns with Hale’s stated vision of Oura becoming a “guardian angel”—an always-present health companion that delivers predictive insights about long-term wellness . The company is already investing heavily in AI to translate complex biometric data into simple, actionable advice, having launched the Oura Advisor chatbot earlier this year . AR glasses would provide the perfect interface for this AI-driven guidance, delivering contextual nudges at the moment they’re most relevant.
The Road Ahead: Build or Partner?
Critical questions remain unanswered. The patent lists Oura Health Oy as the sole applicant, suggesting the company is protecting its intellectual property independently rather than through a partnership . However, developing AR glasses from scratch requires expertise in optics, manufacturing, and supply chain management far removed from Oura’s core competencies in sensor technology and health algorithms.
Hale has indicated a preference for partnerships when expanding beyond the ring form factor, telling CNN that Oura would “consider partnering with other wearables that do special things that are unique and different” . The AR glasses could follow this model: Oura providing the biometric engine and gesture control protocols whilst a specialised hardware partner handles the optical and industrial design.
Alternatively, the patent could represent a defensive move, securing intellectual property territory as the AR wearable market evolves. Many patented concepts never reach commercialisation, and Oura continues to focus heavily on its core ring business, recently launching ceramic versions and a multi-ring charging case .
Implications for the Future of Health Tech
If Oura does pursue this path, it would mark a significant evolution in the wearable industry. The company has built its reputation on discretion, the ring is invisible, silent, and unobtrusive. AR glasses, by their nature, are more conspicuous. Yet they offer something the ring cannot: immediacy. In a world where health monitoring is shifting from reactive to preventive, from periodic to continuous, the ability to see your body’s status in real-time without interrupting your flow could be transformative.
Moreover, the AR glasses patent fits within Oura’s stated roadmap of expanding into “personalised health services” beyond hardware. The company has already integrated glucose monitoring through its partnership with Dexcom, introduced blood testing through Quest Diagnostics, and launched research into blood pressure monitoring with the aim of securing FDA clearance. AR glasses would provide the interface layer for these expanding services, creating a closed loop of measurement, visualisation, and intervention.
Oura’s AR patent extends its existing capability of transforming biometric data into actionable insights from finger to field of vision. The filing addresses the friction of checking a screen whilst leveraging established strengths in sensor accuracy and user trust. Whether this materialises as a proprietary product or licensed platform, it positions Oura to define standards for gesture-controlled health interfaces. The immediate priority remains execution: securing partnerships, proving the technology, and demonstrating tangible value beyond novelty. The move aligns with Hale’s stated vision of a “cloud of wearables” and provides the interface layer for Oura’s expanding personalised health services.
